DOI QR코드

DOI QR Code

A Case Report of a Patient with Miller Fisher Syndrome Treated with Traditional Korean Medicine

  • Kim, Hyo Bin (Department of Acupuncture & Moxibustion, College of Korean Medicine, Daejeon University) ;
  • Jeong, Jeong Kyo (Department of Acupuncture & Moxibustion, College of Korean Medicine, Daejeon University) ;
  • Kim, Myung Kwan (Department of Acupuncture & Moxibustion, College of Korean Medicine, Daejeon University) ;
  • Kim, Jae Ik (Department of Acupuncture & Moxibustion, College of Korean Medicine, Daejeon University) ;
  • Lee, Ye Ji (Department of Acupuncture & Moxibustion, College of Korean Medicine, Daejeon University) ;
  • Jeon, Ju Hyun (Department of Acupuncture & Moxibustion, College of Korean Medicine, Daejeon University) ;
  • Kim, Eunseok (Department of Acupuncture & Moxibustion, College of Korean Medicine, Daejeon University) ;
  • Kim, Jung Ho (Department of Acupuncture & Moxibustion, College of Korean Medicine, Daejeon University) ;
  • Kim, Young Il (Department of Acupuncture & Moxibustion, College of Korean Medicine, Daejeon University)
  • Received : 2018.06.26
  • Accepted : 2018.08.03
  • Published : 2018.08.30

Abstract

The aim of this report is to describe improved symptom changes in eye movement disorders and dizziness of a patient with Miller Fisher syndrome after receiving combined Korean medicine treatment (CKMT). A 24-year-old male was diagnosed with MFS accompanied by eye movement disorder, diplopia, and dizziness. For 6 weeks, the patient received acupuncture, electro-acupuncture, pharmacopuncture, herbal medicine, and physical therapy treatment. Visual analogue scale were checked and other outcomes (the range of eye movement, the distance that diplopia appears, diplopia questionnaire) were measured. Following CKMT, the movement of both eyes improved in both the horizontal and vertical direction. Also for diplopia and dizziness, there was a decrease in the visual analogue scale and the distance that diplopia appeared. The present case report suggests that CKMT may have a role in treating eye movement disorders and dizziness in patient diagnosed with MFS.

Keywords

References

  1. Fischer M. An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). N Engl J Med 1956;255:57-65. https://doi.org/10.1056/NEJM195607122550201
  2. Berlit P, Rakicky J. Miller Fischer syndrome. Review of the literature. J Clin Neurophthalmol 1992;12:57-63.
  3. Lo YL. Clinical and immunological spectrum of the Miller Fisher syndrome. Muscle Nerve 2007;36:615-627. https://doi.org/10.1002/mus.20835
  4. Jonathan MH, Leske DA, Kupersmith MJ. New Methods for Quantifying Diplopia. Ophthalmology 2005;112:2035-2039. https://doi.org/10.1016/j.ophtha.2005.06.013
  5. Holmes JM, Liebermann L, Hatt SR, Smith SJ, Leske DA. Quantifying Diplopia with a Questionnaire. Ophthalmology 2013;120:1492-1496. https://doi.org/10.1016/j.ophtha.2012.12.032
  6. Buchwald B, Weisjaupt A, Toyka KV, Dudel J. Pre-and postsynaptic blockade of neuromuscular transmission by Miller Fisher syndrome IgG at mouse motor nerve terminals. Eur J Neurosci 1998;10:281-290. https://doi.org/10.1046/j.1460-9568.1998.00053.x
  7. Odaka M, Yuki N, Hirata K. Anti-GQ1b IgG antibody syndrome; clinical and immunological range. J Neurol Neurosurg Psychiatry 2001;70:50-55. https://doi.org/10.1136/jnnp.70.1.50
  8. Son MG, Ahn HS. Miller Fisher syndrome. J Korean Ophthalmol Soc 1997;38:1470-1479. [in Korean]
  9. Cheng KJ. Neurobiological Mechanisms of Acupuncture for Some Common Illnesses: A Clinician's Perspective. J Acupunct Meridian Stud 2014;7:105-114. https://doi.org/10.1016/j.jams.2013.07.008
  10. Ryu JY, Lee KW, Cho MK, Cho HK, Yoo HR, Seol IC et al. Case report: Miller Fisher Syndrome. J Int Korean Med 2016;37:661-668. [in Korean] https://doi.org/10.22246/jikm.2016.37.4.661
  11. Li YF, Li T, Zhang DW, Xue H, Chen D, Li C et al. The comprehensive Therapy of Electroacupunture Promotes Regeneration of Nerve Fibers and Motor Function Recovery in Rats after Spinal Cord Injury. Evid Based Complement Alternat Med 2018;2018:7568697.
  12. Lee WR, Kim SJ, Park JH. Bee venom reduces atherosclerotic lesion formation via anti-inflammatory mechanism. Am J Chin Med 2010;38:1077-1092. https://doi.org/10.1142/S0192415X10008482
  13. Behroozi J, Divsalar A, Saboury AA. Honey bee venom decreases the complications of diabetes by preventing hemoglobin glycation. J Mol Liq 2014;199:371-375. https://doi.org/10.1016/j.molliq.2014.09.034
  14. Wesselius T, Heersema DJ, Mostert JP. A randomized crossover study to bee sting therapy for multiple sclerosis. Neurology 2005;65:1764-1768. https://doi.org/10.1212/01.wnl.0000184442.02551.4b
  15. Woo SJ, Shin JW, Jang WS, Baek KM. A Case Report of Treatment of a patient with Neuromyelitis Optica and Suffering from vision Disorder and Quadriplegia with Korean Traditional Medicine. J Intern Korean Med 2017;38:658-667. https://doi.org/10.22246/jikm.2017.38.5.658

Cited by

  1. A Case Study of a Patient with Diplopia and Bilateral Facial Palsy Due to Atypical Miller Fisher Syndrome: Treatment with Complex Korean Medicine vol.38, pp.1, 2021, https://doi.org/10.13045/jar.2020.00367